McKesson Corporation (MCK) financial statements: income statement, balance sheet and cash flow

McKesson Corporation's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Mar 31, 2026 · FY), McKesson Corporation reported revenue of $403.4B (+12.4% year on year) and net income of $5.1B (+46.5% year on year).

Income statement

McKesson Corporation income statement, fiscal years

Line item	Mar 31, 2026 · FY	Mar 31, 2025 · FY	Mar 31, 2024 · FY	Mar 31, 2023 · FY
Revenues	$403.4B	$359.1B	$309.0B	$276.7B
Cost of sales	($388.9B)	($345.7B)	($296.1B)	($264.4B)
Gross profit	$14.6B	$13.3B	$12.8B	$12.4B
Selling, distribution, general, and administrative expenses	($8.1B)	($8.5B)	($8.7B)	($7.8B)
Claims and litigation charges, net	$3.0M	($108.0M)	($147.0M)	$8.0M
Restructuring, impairment, and related charges, net	($245.0M)	($286.0M)	($115.0M)	($209.0M)
Total operating expenses	($8.3B)	($8.9B)	($8.9B)	($8.0B)
Operating income	$6.2B	$4.4B	$3.9B	$4.4B
Other income, net	$236.0M	$202.0M	$132.0M	$497.0M
Interest expense	($247.0M)	($265.0M)	($252.0M)	($248.0M)
Income before income taxes	$6.2B	—	—	—
Income tax expense	($1.1B)	($878.0M)	($629.0M)	($905.0M)
Net income	$5.1B	$3.5B	$3.2B	$3.7B
Net income attributable to noncontrolling interests	($337.0M)	($186.0M)	($158.0M)	($162.0M)
Net income attributable to McKesson Corporation	$4.8B	$3.3B	$3.0B	$3.6B
Diluted (in dollars per share)	$38.38	$25.72	$22.39	$25.03
Basic (in dollars per share)	$38.55	$25.86	$22.54	$25.23
Diluted (in shares)	124.1M	128.1M	134.1M	142.2M
Basic (in shares)	123.6M	127.4M	133.2M	141.1M

McKesson Corporation income statement, quarters

Line item	Jun 30, 2026 · Q1	Dec 31, 2025 · Q3	Sep 30, 2025 · Q2	Jun 30, 2025 · Q1
Revenues	$105.4B	$106.2B	$103.2B	$97.8B
Cost of sales	($101.7B)	($102.5B)	($99.6B)	($94.5B)
Gross profit	$3.7B	$3.7B	$3.5B	$3.3B
Selling, distribution, general, and administrative expenses	($2.3B)	($2.0B)	($2.1B)	($2.2B)
Claims and litigation charges, net	$34.0M	$0	$2.0M	$0
Restructuring, impairment, and related charges, net	($136.0M)	($36.0M)	($63.0M)	($47.0M)
Total operating expenses	($2.4B)	($2.1B)	($2.1B)	($2.2B)
Operating income	$1.3B	$1.6B	$1.4B	$1.0B
Other income, net	$66.0M	$74.0M	$62.0M	$64.0M
Interest expense	($77.0M)	($63.0M)	($74.0M)	($49.0M)
Income before income taxes	$1.3B	$1.6B	$1.4B	$1.1B
Income tax expense	($276.0M)	($380.0M)	($232.0M)	($220.0M)
Net income	$1.0B	$1.3B	$1.2B	$831.0M
Net income attributable to noncontrolling interests	($418.0M)	($64.0M)	($53.0M)	($47.0M)
Net income attributable to McKesson Corporation	$614.0M	$1.2B	$1.1B	$784.0M
Diluted (in dollars per share)	$5.15	$9.59	$8.92	$6.25
Basic (in dollars per share)	$5.17	$9.63	$8.95	$6.28
Diluted (in shares)	119.2M	123.7M	124.4M	125.5M
Basic (in shares)	118.7M	123.2M	124.0M	124.9M

Balance sheet

McKesson Corporation balance sheet, fiscal years

Line item	Mar 31, 2026 · FY	Mar 31, 2025 · FY	Mar 31, 2024 · FY	Mar 31, 2023 · FY
Cash and cash equivalents	$4.0B	$5.7B	$4.6B	$4.7B
Receivables, net	$28.0B	$25.6B	$21.6B	$19.4B
Inventories, net	$24.2B	$23.0B	$21.1B	$19.7B
Prepaid expenses and other	$1.0B	$1.1B	$626.0M	$496.0M
Total current assets	$57.2B	$55.4B	$48.0B	$44.3B
Property, plant, and equipment, net	$2.7B	$2.5B	$2.3B	$2.2B
Operating lease right-of-use assets	$2.1B	$1.8B	$1.7B	$1.6B
Goodwill	$11.3B	$10.0B	$10.1B	$9.9B
Intangible assets, net	$4.1B	$1.5B	$2.1B	$2.3B
Other non-current assets	$5.0B	$4.0B	$3.2B	$2.0B
Total assets	$82.3B	$75.1B	$67.4B	$62.3B
Drafts and accounts payable	$60.0B	$55.3B	$47.1B	$42.5B
Current portion of long-term debt	$1.3B	$1.2B	$50.0M	$968.0M
Current portion of operating lease liabilities	$287.0M	$258.0M	$295.0M	$299.0M
Other accrued liabilities	$5.5B	$4.8B	$4.9B	$4.2B
Total current liabilities	$67.0B	$61.6B	$52.4B	$48.0B
Long-term debt	$5.3B	$4.5B	$5.6B	$4.6B
Long-term deferred tax liabilities	$1.3B	$1.0B	$917.0M	$1.4B
Long-term operating lease liabilities	$1.8B	$1.5B	$1.5B	$1.4B
Long-term litigation liabilities	$5.1B	$5.6B	$6.1B	$6.6B
Other non-current liabilities	$2.7B	$2.7B	$2.6B	$1.8B
Redeemable noncontrolling interests	$943.0M	—	—	—
Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding	0	0	0	0
Common stock, $0.01 par value, 800 shares authorized, 280 and 279 shares issued at March 31, 2026 and 2025, respectively	3.0M	3.0M	3.0M	3.0M
Additional paid-in capital	$8.3B	$8.4B	$8.0B	$7.7B
Retained earnings	$22.3B	$17.9B	$15.0B	$12.3B
Accumulated other comprehensive loss	($745.0M)	($932.0M)	($881.0M)	($905.0M)
Treasury shares, at cost, 160 and 154 shares at March 31, 2026 and 2025, respectively	-32.0B	-27.4B	-24.1B	-21.0B
Total McKesson Corporation stockholders’ deficit	($2.2B)	($2.1B)	($2.0B)	($1.9B)
Noncontrolling interests	$395.0M	$380.0M	$372.0M	$367.0M
Total deficit	($1.8B)	($1.7B)	($1.6B)	($1.5B)
Total liabilities, redeemable noncontrolling interests, and deficit	$82.3B	$75.1B	$67.4B	$62.3B

McKesson Corporation balance sheet, quarters

Line item	Jun 30, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025
Cash and cash equivalents	$5.2B	$3.0B	$4.0B	$2.4B
Receivables, net	$30.3B	$28.2B	$28.3B	$28.2B
Inventories, net	$26.3B	$27.1B	$26.1B	$25.1B
Prepaid expenses and other	$1.1B	$1.5B	$1.5B	$1.2B
Total current assets	$62.8B	$59.7B	$59.9B	$56.8B
Property, plant, and equipment, net	$2.7B	$2.6B	$2.6B	$2.6B
Operating lease right-of-use assets	$1.9B	$2.1B	$2.0B	$2.2B
Goodwill	$11.3B	$11.3B	$11.3B	$11.4B
Intangible assets, net	$4.0B	$4.2B	$4.2B	$4.3B
Other non-current assets	$5.6B	$4.3B	$4.2B	$4.1B
Total assets	$88.3B	$84.2B	$84.2B	$81.3B
Drafts and accounts payable	$63.7B	$60.7B	$60.9B	$57.9B
Current portion of long-term debt	$1.3B	$1.1B	$1.7B	$1.2B
Current portion of operating lease liabilities	$292.0M	$286.0M	$278.0M	$297.0M
Other accrued liabilities	$5.0B	$6.0B	$5.1B	$4.9B
Total current liabilities	$70.4B	$68.1B	$68.0B	$64.3B
Long-term debt	$8.4B	$5.4B	$6.0B	$6.5B
Long-term deferred tax liabilities	$1.4B	$1.1B	$1.1B	$987.0M
Long-term operating lease liabilities	$1.7B	$1.8B	$1.8B	$1.9B
Long-term litigation liabilities	$5.1B	$5.1B	$5.1B	$5.6B
Other non-current liabilities	$2.7B	$2.7B	$2.8B	$2.9B
Redeemable noncontrolling interests	$2.6B	$802.0M	$777.0M	$725.0M
Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding	0	0	0	0
Common stock, $0.01 par value, 800 shares authorized, 280 shares issued at June 30, 2026 and March 31, 2026	3.0M	3.0M	3.0M	3.0M
Additional paid-in capital	$8.6B	$8.5B	$8.5B	$8.4B
Retained earnings	$22.8B	$20.7B	$19.6B	$18.6B
Accumulated other comprehensive loss	($749.0M)	($903.0M)	($908.0M)	($898.0M)
Treasury shares, at cost, 164 and 160 shares at June 30, 2026 and March 31, 2026, respectively	-34.9B	-29.7B	-29.0B	-28.1B
Total McKesson Corporation stockholders’ deficit	($4.2B)	($1.3B)	($1.7B)	($2.0B)
Noncontrolling interests	$376.0M	$397.0M	$384.0M	$379.0M
Total deficit	($3.9B)	($901.0M)	($1.4B)	($1.6B)
Total liabilities, redeemable noncontrolling interests, and deficit	$88.3B	$84.2B	$84.2B	$81.3B

Cash flow statement

McKesson Corporation cash flow statement, fiscal years

Line item	Mar 31, 2026 · FY	Mar 31, 2025 · FY	Mar 31, 2024 · FY	Mar 31, 2023 · FY
Net income	$5.1B	$3.5B	$3.2B	$3.7B
Depreciation	$256.0M	$242.0M	$253.0M	$248.0M
Amortization	$473.0M	$394.0M	$382.0M	$360.0M
Long-lived asset impairment charges	$55.0M	$98.0M	$43.0M	$72.0M
Deferred taxes	$230.0M	($110.0M)	($603.0M)	($20.0M)
Charges (credits) associated with last-in, first-out inventory method	($210.0M)	$82.0M	($157.0M)	$1.0M
Non-cash operating lease expense	$261.0M	$245.0M	$228.0M	$249.0M
Loss (gain) from sales of businesses and investments	($573.0M)	$485.0M	($17.0M)	($211.0M)
Provision for bad debts	$100.0M	($130.0M)	$819.0M	—
Other non-cash items	$302.0M	$424.0M	$233.0M	$298.0M
Receivables	($2.0B)	($3.9B)	($3.0B)	($1.1B)
Inventories	($1.1B)	($2.3B)	($1.3B)	($1.3B)
Drafts and accounts payable	$4.3B	$8.3B	$4.6B	$3.8B
Operating lease liabilities	($270.0M)	($404.0M)	($339.0M)	($338.0M)
Taxes	($339.0M)	($136.0M)	$331.0M	$363.0M
Litigation liabilities	($684.0M)	($401.0M)	($395.0M)	($1.1B)
Other	$219.0M	($281.0M)	$37.0M	$56.0M
Net cash provided by operating activities	$6.2B	$6.1B	$4.3B	$5.2B
Payments for property, plant, and equipment	($436.0M)	($537.0M)	($431.0M)	($390.0M)
Capitalized software expenditures	($309.0M)	($322.0M)	($256.0M)	($168.0M)
Acquisitions, net of cash, cash equivalents, and restricted cash acquired	($3.4B)	($24.0M)	($272.0M)	($867.0M)
Proceeds from sales of businesses and investments, net	$830.0M	$179.0M	$47.0M	$1.1B
Other	($101.0M)	($29.0M)	($160.0M)	($194.0M)
Net cash used in investing activities	($3.4B)	($733.0M)	($1.1B)	($542.0M)
Proceeds from short-term borrowings	$9.2B	$15.1B	$20.0B	$8.4B
Repayments of short-term borrowings	($9.2B)	($15.1B)	($20.0B)	($8.4B)
Proceeds from issuances of long-term debt	$2.0B	$498.0M	$991.0M	$997.0M
Repayments of long-term debt	($1.2B)	($519.0M)	($288.0M)	($1.3B)
Purchase of U.S. government obligations for the satisfaction and discharge of long-term debt	$0	$0	($647.0M)	—
Issuances	89.0M	101.0M	116.0M	163.0M
Share repurchases	($4.8B)	($3.1B)	($3.0B)	($3.6B)
Dividends paid	($381.0M)	($345.0M)	($314.0M)	($292.0M)
Other	($372.0M)	($554.0M)	($175.0M)	($324.0M)
Net cash used in financing activities	($4.6B)	($4.0B)	($3.3B)	($4.4B)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	$20.0M	($16.0M)	$6.0M	$25.0M
Net increase (decrease) in cash, cash equivalents, and restricted cash	($1.9B)	$1.4B	($94.0M)	$744.0M
Cash, cash equivalents, and restricted cash at beginning of year	$6.0B	$4.6B	$4.7B	$3.9B
Cash, cash equivalents, and restricted cash at end of year	$4.1B	$6.0B	$4.6B	$4.7B
Less: Restricted cash at end of year included in Prepaid expenses and other	($93.0M)	($265.0M)	($2.0M)	($1.0M)
Cash and cash equivalents at end of year	$4.0B	$5.7B	$4.6B	$4.7B
Interest, net	$212.0M	$273.0M	$234.0M	$224.0M
Income taxes, net of refunds	$1.2B	$1.1B	$901.0M	$562.0M

McKesson Corporation cash flow statement, quarters

Line item	Jun 30, 2026 · Q1	Dec 31, 2025 · YTD	Sep 30, 2025 · YTD	Jun 30, 2025 · Q1
Net income	$1.0B	$3.2B	$2.0B	$831.0M
Depreciation	$69.0M	$189.0M	$124.0M	$62.0M
Amortization	$126.0M	$344.0M	$221.0M	$95.0M
Asset impairment charges	$47.0M	$10.0M	$4.0M	$2.0M
Deferred taxes	$19.0M	$8.0M	($41.0M)	($8.0M)
Credits associated with last-in, first-out inventory method	($2.0M)	($28.0M)	($18.0M)	($7.0M)
Non-cash operating lease expense	$66.0M	$184.0M	$140.0M	$70.0M
Loss (gain) from sales of businesses and investments	($6.0M)	($85.0M)	($85.0M)	$17.0M
Provision for bad debts	$45.0M	$81.0M	$232.0M	$196.0M
Other non-cash items	$76.0M	$209.0M	$169.0M	$57.0M
Receivables	($2.4B)	($2.1B)	($2.3B)	($2.1B)
Inventories	($2.1B)	($4.1B)	($3.2B)	($2.0B)
Drafts and accounts payable	$3.8B	$4.9B	$5.2B	$1.9B
Operating lease liabilities	($65.0M)	($202.0M)	($152.0M)	($89.0M)
Taxes	($538.0M)	$184.0M	$121.0M	$134.0M
Litigation liabilities	($34.0M)	($669.0M)	($657.0M)	$0
Other	($380.0M)	$602.0M	($225.0M)	($165.0M)
Net cash used in operating activities	($220.0M)	$2.7B	$1.5B	($918.0M)
Payments for property, plant, and equipment	($112.0M)	($325.0M)	($217.0M)	($111.0M)
Capitalized software expenditures	($40.0M)	($235.0M)	($168.0M)	($78.0M)
Acquisitions, net of cash, cash equivalents, and restricted cash acquired	($23.0M)	($3.4B)	($3.4B)	($3.4B)
Proceeds from sales of businesses and investments, net	$9.0M	$137.0M	$133.0M	$4.0M
Other	($48.0M)	($22.0M)	$53.0M	($20.0M)
Net cash used in investing activities	($214.0M)	($3.9B)	($3.6B)	($3.6B)
Proceeds from issuances of long-term debt	$3.2B	$2.0B	$2.0B	$2.0B
Repayments of long-term debt	($1.0M)	($1.2B)	($2.0M)	—
Issuances	23.0M	65.0M	50.0M	22.0M
Share repurchases	($2.5B)	($2.1B)	($1.4B)	($581.0M)
Dividends paid	($102.0M)	($280.0M)	($179.0M)	($90.0M)
Sale of noncontrolling interest in Medical-Surgical Solutions, net	$1.2B	—	—	—
Other	($211.0M)	($308.0M)	($245.0M)	($165.0M)
Net cash provided by financing activities	$1.6B	($1.8B)	$215.0M	$1.2B
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	($10.0M)	$31.0M	$24.0M	$33.0M
Net increase (decrease) in cash, cash equivalents, and restricted cash	$1.2B	($2.9B)	($1.8B)	($3.3B)
Cash, cash equivalents, and restricted cash at beginning of period	$4.1B	$6.0B	$6.0B	$6.0B
Cash, cash equivalents, and restricted cash at end of period	$5.3B	$3.1B	$4.1B	$2.7B
Less: Restricted cash at end of period included in Prepaid expenses and other	($92.0M)	($94.0M)	($105.0M)	($265.0M)
Cash and cash equivalents at end of period	$5.2B	$3.0B	$4.0B	$2.4B

McKesson Corporation score and earnings-call analysis · All covered companies

Figures as reported in SEC filings. General information, not investment advice.